How effective is the Menaflex device?
ReGen presented clinical data from 162 patients who received the device; a year after each surgery, the clinical investigators conducted a second surgery on 141 of those patients to assess the condition of the device, tissue development and the joint. On average, there was 70 percent more tissue present at these “relooks” than after the original partial meniscectomy. It is known from scientific literature that meniscus tissue does not regenerate on its own after partial meniscectomy. Biopsies taken from 135 patients showed that the new tissue was meniscus-like. Patients who received the Menaflex device experienced a statistically significant improvement in levels of pain, function, self-assessment and activity over their pre-surgical levels.
